SCHEMBL2847199

SCHEMBL2847199

COC(=O)c1ccc(CN(C)C(=O)OC(C)(C)C)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.46
NPSR1 Q6W5P4 2/20 0.46
TSHR P16473 2/20 0.46
MAPK1 P28482 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MRGPRX4 Q96LA9 1/20 0.41
LMNA P02545 1/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
RIPK1 Q13546 1/20 0.40
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
PARP1 P09874 1/20 0.37
HTR2C P28335 1/20 0.37
SLC6A4 P31645 1/20 0.37
HDAC3 O15379 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2846285 0.89 RIPK1 (0.42) MRGPRX4RIPK1ALDH1A1HTR2CSLC6A4
SCHEMBL30466784 0.86 RIPK1 (0.42) HPGDNPSR1TSHRL3MBTL1LMNA
SCHEMBL25746083 0.83 GSK3B (0.42) RIPK1ALDH1A1MAPTHTR2CSLC6A4
SCHEMBL22652350 0.81 NPSR1 (0.45) HPGDNPSR1TSHRMAPK1ATM
SCHEMBL22652248 0.79 NPSR1 (0.49) HPGDNPSR1TSHRMAPK1ATM
SCHEMBL30466777 0.79 AR (0.44) L3MBTL1RIPK1ALDH1A1KDM4EHTR2C
SCHEMBL11493054 0.78 RIPK1 (0.42) HPGDL3MBTL1RIPK1ALDH1A1MAPT
SCHEMBL30466792 0.77 RIPK1 (0.41) RIPK1ALDH1A1HTR2CSLC6A4GLS
SCHEMBL277557 0.76 HPGD (0.46) HPGDNPSR1TSHRMAPK1ATM
SCHEMBL28211212 0.76 HPGD (0.46) HPGDNPSR1TSHRMAPK1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100130471-A1 Renin Inhibitors SMITHKLINE BEECHAM CORPORATION 2010-05-27 US disclosed
US-20100130471-A1 Renin Inhibitors SMITHKLINE BEECHAM CORPORATION 2010-05-27 US disclosed
WO-2008124582-A1 RENIN INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-10-16 WO disclosed
WO-2008124582-A1 RENIN INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100130471-A1 Renin Inhibitors ACE, REN, DNPEP HPGD 697/4885NPSR1 1490/4885TSHR 3864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.